Pharmacological evidence for a receptor mediating sustained nucleotide-evoked contractions of rat aorta in the presence of UTP

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 225-235

  López, Covadonga ^a   Sánchez, Manuel ^a   Hidalgo, Agustín ^a   García de Boto, María José ^a  

^a Faculty de Medicina   (Spain)

Author keywords

Aorta, rat; ATP; Nucleotide receptor; Smooth muscle, vascular; UTP

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENINE; ADENOSINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE; DEOXYADENOSINE TRIPHOSPHATE; GUANOSINE DIPHOSPHATE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; INOSINE TRIPHOSPHATE; MEMBRANE RECEPTOR; NUCLEOTIDE; PERTUSSIS TOXIN; PURINE P2X RECEPTOR; THYMIDINE TRIPHOSPHATE; URACIL; URIDINE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL TISSUE; AORTA STRIP; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0344906165     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00186-1     Document Type: Article

References (27)

1. Abebe W., Edwards J.D., Agrawal D.K. G-proteins in rat blood vessels: II. Assessment of functional involvement. Gen. Pharmacol. 26:1995;75-83.
2. Barnard E.A., Burnstock G., Webb T.E. G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 15:1994;67-70.
3. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
4. Burnstock, G., 1978. A basis for distinguishing two types of purinergic receptors, in: Staub, R.W., Bolis, L. (Eds.), Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, Raven Press, New York, pp. 107-118.
5. Burnstock G. Purinergic mechanisms. Ann. N.Y. Acad. Sci. 603:1990;1-17.
6. 2-purinoceptor? Gen. Pharmacol. 16:1985;433-440.
7. 2X-purinoceptor. Br. J. Pharmacol. 90:1987;382-391.
8. Crack B.E., Pollard C.E., Beukers M.W., Roberts S.M., Hunt S.F., Ingall A.H., McKechnie K.C.W., IJzerman A.P., Leff P. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol. 114:1995;475-481.
9. 2-purinoceptor antagonist in the mouse vas deferens. Br. J. Pharmacol. 93:1988;243-245.
10. 2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol. 113:1994;853-860.
11. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
12. García-Velasco G., Sánchez M., Hidalgo A., García de Boto M.J. Pharmacological dissociation of UTP- and ATP-elicited contractions and relaxations in isolated rat aorta. Eur. J. Pharmacol. 294:1995;521-529.
13. Goetz V., Prada D.A., Pletscher M.A. Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J. Pharmacol. Exp. Ther. 178:1971;210-215.
14. Gordon J.L. Extracellular ATP: effects, sources and fate. Biochem. J. 233:1986;309-319.
15. Illes P., Nörenberg W. Neural ATP receptors and their mechanism of action. Trends Pharmacol. Sci. 14:1993;50-54.
16. 2-purinoceptor, effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur. J. Pharmacol. 86:1983;291-294.
17. 2X purinoceptors be classified pharmacologically? Trends Pharmacol. Sci. 16:1995;168-174.
18. Lazarowski E.R., Harden T.K. Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem. 269:1994;11830-11836.
19. Lustig K.D., Shiau A.K., Brake A.J., Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 90:1993;5113-5117.
20. Molina R., Hidalgo A., García de Boto M.J. Influence of mechanical endothelium removal techniques and conservation conditions on rat aorta responses. Meth. Find. Exp. Clin. Pharmacol. 14:1992;91-96.
21. Sánchez-Fernández M., Katz G.M., Suarez-Kurtz G., Kaczorowski G.J., Reuben J.P. Mobilization of intracellular calcium in cultured vascular smooth muscle cells by uridine triphosphate and the calcium ionophore A23187. J. Membrane Biol. 135:1993;273-287.
22. 2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci. 18:1995;224-229.
23. Tallarida, R.J., Murray, R.B., 1987. Manual of pharmacological calculations with computer programs, second edn., Springer, New York.
24. 2X receptor for extracellular ATP. Nature. 371:1994;516-519.
25. 2X-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn-Schmiedebergs Arch. Pharmacol. 341:1990;538-546.
26. Von Kügelgen I., Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol. Sci. 12:1991;319-324.
27. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., Barnard E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324:1993;219-225.